Editorial Comment on: Safety and Tolerability of Adjuvant Topical Tacrolimus Treatment in Boys with Lichen Sclerosus: A Prospective Phase 2 Study

European Urology

Volumn 54, Issue 4, 2008, Pages 937-

  Barbagli, Guido ^a   Lazzeri, Massimo ^b  

^a Center for Urethral and Genitalia Reconstructive Surgery   (Italy)

^b Santa Chiara Hospital GIOMI group   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID DERIVATIVE; TACROLIMUS;

CLINICAL TRIAL; DRUG SAFETY; DRUG TOLERABILITY; GENITAL SYSTEM; HUMAN; INCIDENCE; LICHEN SCLEROSUS ET ATROPHICUS; MEDICAL SOCIETY; NOTE; PRECANCER; PRIORITY JOURNAL; PRURITUS; QUALITY OF LIFE; SEXUAL FUNCTION; SKIN REDNESS; URETHRA STRICTURE;

ADMINISTRATION, TOPICAL; CHEMOTHERAPY, ADJUVANT; CHILD; CLINICAL TRIALS, PHASE II AS TOPIC; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LICHEN SCLEROSUS ET ATROPHICUS; MALE; PROSPECTIVE STUDIES; TACROLIMUS;

EID: 50849139581     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2008.03.014     Document Type: Note

References (5)

1. Ebert A.K., Rösch W.H., and Vogt T. Safety and tolerability of adjuvant topical tacrolimus treatment in boys with lichen sclerosus: a prospective phase 2 study. Eur Urol 54 (2008) 932-937
2. Powell J.J., and Wojnarowska F. Lichen sclerosus. Lancet 353 (1999) 1777-1783
3. Palminteri E., Berdondini E., Lazzeri M., Mirri F., and Barbagli G. Resurfacing and reconstruction of the glans penis. Eur Urol 52 (2007) 893-900
4. Barbagli G., De Angelis M., Palminetri E., and Lazzeri M. Failed hypospadias repair presenting in adults. Eur Urol 49 (2006) 887-895
5. Bracka A. Editorial comment. Eur Urol 49 (2006) 895